Treatment of Hospital-Acquired Infections in Patients with Cirrhosis - New Challenges.
Dadasaheb G MaindadSuresh ShenoySuchitra M ShenoySandeep GopalBailuru Vishwanath TantryPublished in: Infection and drug resistance (2022)
Cirrhosis patients with HA infection possess higher prevalence of MDR and XDR infections. In such sick patients, cephalosporin and quinolones are not the appropriate empirical antibiotics. Herein, we propose a tigecycline with carbapenem like meropenem and vancomycin based empirical antibiotics protocol to be prescribed for such patients. De-escalation is advised after the culture sensitivity report is obtained.